OverviewChartNewsTraderScreen

Morgan Stanley Call 150 6MK 21.03.../  DE000MB5NKF2  /

Stuttgart
24/06/2024  17:14:07 Chg.+0.070 Bid24/06/2024 Ask24/06/2024 Underlying Strike price Expiration date Option type
0.390EUR +21.88% 0.390
Bid Size: 50,000		 0.400
Ask Size: 50,000		 MERCK CO. D... 150.00 - 21/03/2025 Call
GlobeNewswire 13:00 Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 05/06 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 03/06 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 29/05 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 29/05 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 29/05 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 06/05 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 02/05 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 02/04 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 06/03 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 04/03 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02/02 Merck Group to expand investment in South Korea
TeleTrader 01/02 Merck's Q4 sales up 6% to $14.6B
TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 23/01 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 21/12/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 19/12/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...
GlobeNewswire 14/12/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...
GlobeNewswire 05/12/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...
GlobeNewswire 04/12/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule